Addiction Clinical Trial
Official title:
Effects of Repetitive tDCS on ad Libitum Smoking Behavior: An EMA and EEG Study
NCT number | NCT03027687 |
Other study ID # | NL58190.078.16 |
Secondary ID | |
Status | Completed |
Phase | N/A |
First received | |
Last updated | |
Start date | October 2016 |
Est. completion date | July 2018 |
Verified date | November 2018 |
Source | Erasmus Medical Center |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
Bilateral (left cathodal/ right anodal) transcranial Direct Current Stimulation (tDCS) over
the dorsolateral prefrontal cortex (DLPFC) seems to reduce craving and to increase the time
till smoking the first cigarette after the intervention. The current study explores whether
actual cigarette consumption decreases after repetitive tDCS. Cigarette consumption and
craving will therefore be measured by means of EMA, before (at baseline), during and after
multiple tDCS sessions, and at 3 months follow-up.
To study the working mechanism behind the effects of tDCS, electrophysiological responses
(ERPs) and behavioral measures of cognitive control functioning will be taken into account at
baseline, one day after the last tDCS session and at three months follow up.
We hypothesize that cigarette consumption will decrease after repetitive tDCS, and that this
effect is associated with better cognitive control functioning.
Status | Completed |
Enrollment | 73 |
Est. completion date | July 2018 |
Est. primary completion date | March 2018 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 18 Years to 65 Years |
Eligibility |
Inclusion Criteria: - Currently smoking 10 or more cigarettes a day - The ability to speak, read, and write in Dutch at an eight-grade literacy level Exclusion Criteria: - The current abuse of a substance other than nicotine or caffeine - History of neurological or psychiatric disorders - Any contraindication for electrical brain stimulation procedures such as electronic implants or metal implants - Pregnancy or breast-feeding - In the process of quitting smoking |
Country | Name | City | State |
---|---|---|---|
Netherlands | Erasmus University | Rotterdam | Zuid-Holland |
Lead Sponsor | Collaborator |
---|---|
Erasmus Medical Center |
Netherlands,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Mean number of cigarettes a day at 3 months follow up | The mean number of cigarettes will be measured at three months follow-up by means of Ecological Momentary Assessments (EMA). This means that participants are asked to report every cigarette they smoke at the moment they're about to smoke it with an app on their mobile phone. Participants do this during the week before the last EEG session at three months follow-up.The mean number will be calculated over this week | 3 months | |
Secondary | Mean number of cigarettes a day one week after tDCS | The mean number of cigarettes will be measured at one week after the last tDCS session by means of Ecological Momentary Assessments (EMA). This means that participants are asked to report every cigarette they smoke at the moment they're about to smoke it with an app on their mobile phone. Participants do this for one week starting from the last tDCS session. The mean number will be calculated over this week | 1 week | |
Secondary | Craving at 3 months follow-up | Participants receive 4 prompts a day in the app on the smartphone to fill out questions about craving for 1 week starting the week before the last EEG session at three months follow-up | 3 months | |
Secondary | Affect 3 months after tDCS | Participants receive 4 prompts a day in the app on the smartphone to fill out questions about affect for 1 week starting the week before the last EEG session at three months follow-up | 3 months | |
Secondary | Craving one week after tDCS | Participants receive 4 prompts a day in the app on the smartphone to fill out questions about craving for 1 week starting the day after the last tDCS session | 1 week | |
Secondary | Affect one week after tDCS | Participants receive 4 prompts a day in the app on the smartphone to fill out questions about affect for 1 week starting the day after the last tDCS session | 1 week | |
Secondary | Behavioral responses of risk-taking | Measured with the two-choice gambling task: proportion of high-risk (higher values) choices | 3 times: at baseline, one day after all tDCS sessions, and at 3 months follow-up | |
Secondary | Behavioral responses of inhibitory control | Measured by proportion correctly inhibited NoGo trials on the Go/NoGo task | 3 times: at baseline, one day after all tDCS sessions, and at 3 months follow-up | |
Secondary | Feedback Related Negativity (FRN): Event Related potential (ERP) of reward processing | Measured with the two choice gambling task. After the choice (high/low risk) is made, participants receive feedback (either they lose or win). The Feedback Related Negativity (FRN) will be measured after feedback by means of EEG. | 3 times: at baseline, one day after all tDCS sessions, and at 3 months follow-up | |
Secondary | Reward related P300: Event related potential (ERP) of reward processing | Measured with the two choice gambling task. After the choice (high/low risk) is made, participants receive feedback (either they lose or win). The reward related P300 will be measured 300-500 ms after feedback by means of EEG. | 3 times: at baseline, one day after all tDCS sessions, and at 3 months follow-up | |
Secondary | N200: Event related potential (ERP) of inhibitory control | The N200 will be measured after NoGo trials in the Go/NoGo task | 3 times: at baseline, one day after all tDCS sessions, and at 3 months follow-up | |
Secondary | P300: Event related potential (ERP) of inhibitory control | The P300 will be measured after NoGo trials in the Go/NoGo task | 3 times: at baseline, one day after all tDCS sessions, and at 3 months follow-up | |
Secondary | Error related negativity: Event related potential (ERP) of error processing | Wrong responses to Go and NoGo trials in the Go/NoGo task will be used to assess the error related negativity (ERN) | 3 times: at baseline, one day after all tDCS sessions, and at 3 months follow-up | |
Secondary | Course of cigarette consumption | Number of cigarettes (and craving) a day starting on the first tDCS day until one week after the last tDCS intervention | 2 weeks |
Status | Clinical Trial | Phase | |
---|---|---|---|
Terminated |
NCT03576768 -
QuitFast: Evaluating Transcranial Magnetic Stimulation as a Tool to Reduce Smoking Directly Following a Quit Attempt
|
N/A | |
Completed |
NCT04110626 -
Realistic Evaluation of Expériences Animées, a School-based Intervention in Nouvelle Aquitaine
|
||
Completed |
NCT03007940 -
Using NIATx Strategies to Implement Integrated Services in Routine Care
|
N/A | |
Not yet recruiting |
NCT04030858 -
The INFINITE Study: A Prospective Investigation of a Nutrient-dense Diet in Early Addiction Recovery
|
N/A | |
Completed |
NCT03347643 -
The Effectiveness of tDCS on Internet Game Addiction
|
Phase 2 | |
Active, not recruiting |
NCT02836080 -
Integrated Collaborative Care Teams for Youth With Mental Health and/or Addiction Challenges (YouthCan IMPACT)
|
N/A | |
Completed |
NCT03221985 -
ESM Pilot: Mobile Phones and Psychology
|
N/A | |
Completed |
NCT02556060 -
Lamotrigine for Ketamine Dependence Trial
|
Phase 2/Phase 3 | |
Completed |
NCT02812810 -
Evaluation of the Efficacy of Repetitive Transcranial Magnetic Stimulation (rTMS) Low-frequency on Craving in Smoking Dependence
|
N/A | |
Completed |
NCT01531153 -
Cognitive Enhancement as a Target for Cocaine Pharmacotherapy
|
N/A | |
Recruiting |
NCT05976646 -
Phase Ib/2a Drug-drug Interaction Study of a Combination of 45mg Dextromethorphan With 105 mg Bupropion
|
Phase 1/Phase 2 | |
Completed |
NCT04409106 -
The Turkish Version of the Parental Smartphone Use Management Scale (PSUMS)
|
||
Not yet recruiting |
NCT06459609 -
Effect of Protein Supplementation on Craving in Subjects Hospitalised for Addiction Treatment
|
N/A | |
Recruiting |
NCT05595759 -
Violence Against Women in Patients With Alcohol Substance Addiction Training
|
N/A | |
Completed |
NCT04099173 -
A Brief Mindfulness-Based Intervention for Suicidal Ideation
|
N/A | |
Recruiting |
NCT04959643 -
Systematic Screening for Viral Hepatitis B and C at the PASS Consultation of the Montpellier University Hospital
|
||
Completed |
NCT04133688 -
Mobile App in Addiction
|
N/A | |
Recruiting |
NCT04063267 -
Electronic Cigarettes as a Harm Reduction Strategy in Individuals With Substance Use Disorder
|
Phase 2 | |
Completed |
NCT05114577 -
Recovery Sleepers: A Pilot Study of a Sleep Health Intervention for College Students in Recovery
|
N/A | |
Terminated |
NCT02671240 -
Prognosis of Behavioral Addiction in Parkinson's Disease
|